Foxp3+ T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid

Clinical Immunology

Volumn 129, Issue 3, 2008, Pages 394-400

  Li, H B ^a,b   Cai, K M ^b   Liu, Z ^c   Xia, J H ^c   Zhang, Y ^c   Xu, R ^a   Xu, G ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chronic rhinosinusitis (CRS); ; Foxp3; ; IL 10; ; Nasal polyps(NP); ; Steroid; T Regulatory cells (Tregs);

Indexed keywords

INTERLEUKIN 10; MOMETASONE FUROATE; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NOSE MUCOSA; NOSE POLYP; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE HOMOGENATE; TISSUE LEVEL; TREATMENT DURATION; WESTERN BLOTTING;

ADMINISTRATION, INTRANASAL; ADULT; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; PREGNADIENEDIOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 55249119729     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.07.031     Document Type: Article

References (23)

1. Pawankar R. Nasal polyposis: an update. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 1-6
2. Bateman N.D., Fahy C., and Woolford T.J. Nasal polyps: still more questions than answers. J. Laryngol. Otol. 117 (2003) 1-9
3. Fokkens W., Lund V., Bachert C., et al. EAACI. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 60 (2005) 583-601
4. Meltzer E.O., Hamilos D.L., Hadley J.A., et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J. Allergy Clin. Immunol. 114 (2004) S155-S212
5. Van Zele T., Claeys S., Gevaert P., et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61 (2006) 1280-1289
6. Bachert C., Gevaert P., Holtappels G., et al. Nasal polyposis: from cytokines to growth. Am. J. Rhinol. 14 (2000) 279-290
7. Robinson S., Douglas R., and Wormald P.J. The relationship between atopy and chronic rhinosinusitis. Am. J. Rhinol. 20 6 (2006) 625-628
8. Shi H.Z., and Qin X.J. CD4CD25 regulatory T lymphocytes in allergy and asthma. Allergy 60 (2005) 986-995
9. Grindebacke H., Wing K., Andersson A.C., et al. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin. Exp. Allergy 34 (2004) 1364-1372
10. Dao Nguyen X., and Robinson D.S. Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J. Allergy Clin. Immunol. 114 (2004) 296-301
11. Xu G., Mou Z., Jiang H., et al. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis. Laryngoscope 117 (2007) 876-880
12. Curotto de Lafaille M.A., and Lafaille J.J. CD4(+) regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14 (2002) 771-778
13. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
14. Sanchez-Segura A., Brieva J.A., and Rodriguez C. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J. Allergy Clin. Immunol. 102 (1998) 953-960
15. Liu Z., Kim J., Sypek J.P., et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J. Allergy Clin. Immunol. 114 (2004) 783-790
16. Small C.B., Hernandez J., Reyes A., et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J. Allergy Clin. Immunol. 116 (2005) 1275-1281
17. Nelson H.S. Mechanisms of intranasal steroids in the management of upper respiratory allergic diseases. J. Allergy Clin. Immunol. 104 (1999) S138-S143
18. Li H., Wen W., Cheng L., et al. Expression of chloride channel protein CLC-3 in patients with allergic rhinitis: effect of topical corticosteroid treatment. Arch Otolaryngol. Head Neck Surg. 134 (2008) 301-305
19. Yariktas M., Doner F., Sutcu R., et al. The effect of topical corticosteroid on basic fibroblast growth factor in nasal polyp tissue. Am. J. Rhinol. 19 (2005) 248-250
20. Chen X., Oppenheim J.J., Winkler-Pickett R.T., et al. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 36 (2006) 2139-2149
21. Malmhäll C., Bossios A., Pullerits T., and Lötvall J. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. Allergy 62 (2007) 1007-1013
22. Karagiannidis C., Akdis M., Holopainen P., et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114 (2004) 1425-1433
23. Cepika A.M., Marinic I., Morovic-Vergles J., et al. Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 16 (2007) 374-377